Scroll To Top

fda approval

CVS Health denies coverage for  breakthrough HIV drug, committing 'clear violation' of ACA

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."

FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent

Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.

FDA Approves Generic Version of Truvada

The availability of a generic version likely means a lower cost of PrEP.

FDA Approves PrEP for Gay and Bi Teens

Youth can now benefit from the HIV prevention treatment.

FDA approves three-in-one antiretroviral pill

The Food and Drug Administration on Wednesday approved Atripla, a combination pill containing three anti-HIV drugs that's taken just once daily. The pill will be the simplest antiretroviral regimen ever available in the United States.